4
Changes in Ownership
SAB Biotherapeutics, Inc. Filed Acc 0001437749-23-006911
Options or other derivatives
- Chief Executive Officer acquired 525,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sullivan Eddie Joe Chief Executive Officer | 2023-03-14 | Grant or award · Employee Stock Option (right to buy) | +525,000 | 525,000 | D: show line 1 in the form |
Loading xslF345X03/rdgdoc.xml…